Skip to main content
. Author manuscript; available in PMC: 2021 Jun 1.
Published in final edited form as: Osteoporos Int. 2020 Feb 10;31(6):1097–1104. doi: 10.1007/s00198-019-05155-8

Table 3:

Visit 3 Sample Characteristics and Univariable Risks of Falls Over 3 Years Using Poisson Regression (n=2,928)

Variable Distribution
Univariable Risks of Falls Over 3 Years Using Poisson Regressiona,b
Mean ± SD or N (%) RR per SD 95% CI p-value
Age, years 79.2 ± 5.2 1.26 1.20, 1.32 <.001
Race/ethnicity
non-white 330 (11) REF
White 2598 (89) 1.40 1.17, 1.67 <.001
Height, cm 173.2 ± 6.9 0.97 0.92, 1.02 .247
Weight, kg 81.4 ± 13.5 0.99 0.94, 1.05 .800
Body mass index, kg/m2 27.1 ± 3.9 1.01 0.96, 1.06 .753
Blocks measure of kyphosis, 1.7cm block 2.6 ± 1.4 1.17 1.11, 1.23 <.001
Total hip BMD, g/cm2 0.939 ± 0.148 0.92 0.87, 0.97 .003
Smoking status
never 1164 (40) REF
past or current 1762 (60) 0.97 0.88, 1.07 .565
Drinks per week 4.1 ± 6.2 0.98 0.93, 1.03 .391
Medicationc use
No 2491 (85) REF
Yes 437 (15) 1.77 1.58, 1.99 <.001
Ever had osteoporosis
No 2704 (92) REF
Yes 224 (8) 1.41 1.19, 1.65 <.001
Comorbiditiesd
No 2269 (77) REF
Yes 659 (23) 1.32 1.18, 1.47 <.001
Fallen in the past year
No 2041 (70) REF
Yes 887 (30) 3.19 2.92, 3.49 <.001
Trouble with dizziness
No 2102 (72) REF
Yes 826 (28) 1.71 1.55, 1.89 <.001
Chair stand time, sec 11.8 ± 3.8 1.21 1.17, 1.26 <.001
Walking speed, m/sec 1.23 ± 0.24 0.74 0.70, 0.78 <.001
Teng 3MS Exam scoree 92.0 ± 7.1 0.90 0.86, 0.94 <.001
Self-rated quality of health
good or excellent 2514 (86) REF
fair or poor or very poor 411 (14) 1.53 1.35, 1.73 <.001
a

All models adjusted for clinic site

b

RRs are presented per standard deviation increase in predictor variable

c

Medications include benzodiazepines, opioid analgesics, and SSRI or tricyclic antidepressants

d

Comorbidities include Parkinson disease, diabetes, or history of stroke

e

Teng Modified Mini-Mental Status Exam